Evidence map›Paper›PMID 40989640›Full record

ReviewOpen veterinary journal2025

A new Egyptian approach to the antibacterial effect of zinc oxide nanoparticles on zoonotic bacteria with different transmission patterns isolated from cattle.

Asmaa I Zin Eldin, Heba F Hozyen, Eman Shafik, Nourhan Eissa

Abstract readReview
In one paragraph

Review in Open veterinary journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Asmaa I Zin EldinDepartment of Microbiology and Immunology, National Research Center (NRC), Giza, Egypt.
Heba F HozyenDepartment of Animal Reproduction and AI, National Research Center (NRC), Giza, Egypt.
Eman ShafikDepartment of Microbiology and Immunology, National Research Center (NRC), Giza, Egypt.
Nourhan EissaDepartment of Animal Hygiene and Zoonoses, Faculty of Veterinary Medicine, University of Sadat City, Sadat City, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cattle mastitis is a widespread and affluent illness that threatens the dairy industry. Numerous common infectious diseases, mostly zoonotic, impact Egypt's dairy cow production. According to their remarkable affordability, high safety, and biocompatibility, and their exceptional effectiveness against microbes, zinc oxide nanoparticles (ZnO-NPs) have shown great promise in biomedicine, particularly in the areas of antibacterial and anticancer treatment, and so have become the most broadly used nanoparticles of metal oxides in various biological treatments throughout the last 20 years. Aim: The present study emphasized the potential for dispersed, non-agglomerated ZnO-NPs produced by sonochemical irradiation with starch serving as a capping agent to be considered more economical and effective germicidal agents in the eradication of bacteria of bovine mastitis, such as Methods: To improve their antibacterial effectiveness against specific zoonotic pathogens that can cause bovine mastitis, three suspensions of ZnO-NPs were created as follows: auto-combustion reaction-synthesized ZnO-NPs, auto-combustion reaction-prepared uncapped ZnO-NPs, and sonochemically prepared starch-capped ZnO-NPs. The three suspensions were exposed to the zoonotic pathogens Results: The prepared three nano-ZnO suspensions showed minimum bactericidal concentration (MBC) total suppression of Conclusion: This point will be useful for future research on ZnO-NPs because it focuses on their biological and antibacterial applications.

Indexed as

Anti-Bacterial AgentsMastitis, BovineMetal NanoparticlesNanoparticlesZinc OxideAnimalsBacterial ZoonosesCattleEgyptEnterococcus faeciumFemaleMicrobial Sensitivity TestsPseudomonas aeruginosaSalmonella typhimuriumStaphylococcus epidermidisAnti-Bacterial AgentsZinc OxideAntibiotic residues.Bovine mastitisEgyptZinc oxide nanoparticlesZoonoses

Identifiers

PMID40989640
PMCPMC12451179

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.